GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abeona Therapeutics Inc (FRA:PCJ) » Definitions » FCF Yield %

Abeona Therapeutics (FRA:PCJ) FCF Yield % : -21.76 (As of May. 13, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Abeona Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Abeona Therapeutics's Trailing 12-Month Free Cash Flow is €-34.62 Mil, and Market Cap is €159.15 Mil. Therefore, Abeona Therapeutics's FCF Yield % for today is -21.76%.

The historical rank and industry rank for Abeona Therapeutics's FCF Yield % or its related term are showing as below:

FRA:PCJ' s FCF Yield % Range Over the Past 10 Years
Min: -391.53   Med: -18.27   Max: 0.06
Current: -21.76


During the past 13 years, the highest FCF Yield % of Abeona Therapeutics was 0.06%. The lowest was -391.53%. And the median was -18.27%.

FRA:PCJ's FCF Yield % is ranked worse than
59.81% of 1555 companies
in the Biotechnology industry
Industry Median: -14.28 vs FRA:PCJ: -21.76

Abeona Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Abeona Therapeutics FCF Yield % Historical Data

The historical data trend for Abeona Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abeona Therapeutics FCF Yield % Chart

Abeona Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -248.72 -103.62 -139.91 -90.06 -28.50

Abeona Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -115.77 -98.14 -48.85 -24.20 -28.30

Competitive Comparison of Abeona Therapeutics's FCF Yield %

For the Biotechnology subindustry, Abeona Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abeona Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abeona Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Abeona Therapeutics's FCF Yield % falls into.



Abeona Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Abeona Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-34.241 / 120.153267
=-28.50%

Abeona Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-8.502 * 4 / 120.153267
=-28.30%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abeona Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Abeona Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Abeona Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abeona Therapeutics (FRA:PCJ) Business Description

Traded in Other Exchanges
Address
1330 Avenue of the Americas, 33rd Floor, New York, NY, USA, 10019
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

Abeona Therapeutics (FRA:PCJ) Headlines

No Headlines